MRLs for sodium salicylate in poultry
Published by AGRINFO on
EU proposes MRLs for sodium salicylate in chicken and poultry (other than turkey)
Draft Commission Implementing Regulation amending Regulation (EU) No 37/2010 as regards the classification of the substance sodium salicylate with respect to its maximum residue limit in foodstuffs of animal origin
Draft Annex to Regulation 37/2010
The EU is proposing maximum residue levels (MRLs) for sodium salicylate in poultry tissues other than turkey, but not in poultry producing eggs.
What is changing?
The European Commission proposes the following MRLs for for sodium salicylate in poultry tissues other than turkey:
- muscle, and skin and fat in natural proportion: 250 μg/kg
- liver: 500 μg/kg
- kidney: 1000 μg/kg
Sodium salicylate may not be used in poultry that is producing eggs for human consumption, because a lack of data means MRLs for eggs cannot be set.
The Annex to Regulation 37/2010 on pharmacologically active substances and their MRLs in food of animal origin will be amended accordingly.
The European Medicines Agency (EMA) concluded that the MRLs for sodium salicylate from chicken tissues can be extended to those of other poultry except turkey (for which MRLs are in place already), but not to poultry eggs. This is because no residue data for sodium salicylate in eggs were provided.
Competent authorities of countries that are members of the World Trade Organization (WTO) can submit comments on the EU’s proposal by emailing the EU SPS Enquiry Point until 15 January 2024.
Expected date of adoption: February 2024.
Expected date of publication: March 2024.
Countries that export poultry muscle, liver, kidney, and skin and fat in natural proportion must ensure that the MRLs for sodium salicylate in those products destined for the EU are not exceeded.
They must also ensure that sodium salicylate is not used for poultry producing eggs for human consumption.
The Annex to Regulation 37/2010 sets MRLs for sodium salicylate in turkey. No MRL is required for oral use of sodium salicylate in cattle and pigs. The substance is not allowed for oral use in animals producing milk for human consumption.
In September 2022, Dopharma B.V. submitted an application to the EMA for the use of sodium salicylate in chicken. In October 2023 the EMA, based on the opinion of the Committee for Veterinary Medicinal Products, recommended that MRLs be set for its use in chicken, and that these MRLs should apply also to other poultry except turkey (for which MRLs were in place already).
Online resources from the European Commission:
Draft Commission Implementing Regulation amending Regulation (EU) No 37/2010
Draft Annex to Regulation 37/2010
Regulation 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin
Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.